Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models. (7th November 2013) - He, Li-Zhen; Thomas, Lawrence J; Testa, James; Weidlick, Jeffrey; Sisson, Crystal; Hammond, Russell; Vitale, Laura; Marsh, Henry; Keler, Tibor